Treatment

TherVacB (HEPLISAV B +/- HBcoreAg + MVA-HBVac) clinical trials

1 indexed studies · 1 currently recruiting

Enrolling by invitationPHASE1, PHASE2
TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate
This study is testing a new hepatitis B vaccine called TherVacB. It aims to see if it's safe and helps the body fight the hepatitis B virus in people who are already taking medication for it.
For: Chronic Hepatitis B
Germany